Indira Gandhi Eye Hospital Achieves Milestone with First iStent Inject W Procedure

Indira Gandhi Eye Hospital Achieves Milestone with First iStent Inject W Procedure

Uttar Pradesh – Indira Gandhi Eye Hospital proudly announces a significant advancement in glaucoma care with the successful implantation of the first iStent Inject W at the institution, performed by renowned Glaucoma surgeon Dr. Shweta Tripathi. This landmark procedure also marks the second implantation of iStent Inject W in the state of Uttar Pradesh, reinforcing the hospital’s commitment to adopting cutting-edge, minimally invasive glaucoma treatments.

Glaucoma, often referred to as the “silent thief of sight,” is a progressive optic neuropathy that can lead to irreversible vision loss if not managed effectively. Traditional management has relied heavily on long-term topical medications, which can be associated with poor compliance and ocular surface disease. The introduction of iStent Inject W, a minimally invasive glaucoma surgery (MIGS) device, represents a paradigm shift in treatment by enhancing physiological outflow and reducing intraocular pressure (IOP) with a strong safety profile.

Dr. Shweta Tripathi, who led the procedure, stated:
“This is an important step forward for glaucoma patients in our region. With iStent Inject W, we can offer a safer, effective, and less invasive option that reduces dependence on medications and improves quality of life.”

The iStent Inject W device is implanted into the trabecular meshwork to restore the eye’s natural drainage system. The procedure is typically combined with cataract surgery and involves minimal tissue disruption, allowing for faster recovery and fewer complications compared to traditional filtering surgeries.

The patient who underwent the procedure at Indira Gandhi Eye Hospital is recovering well, with stable intraocular pressure and no immediate complications reported. This success highlights the hospital’s growing expertise in advanced glaucoma management and its dedication to bringing global innovations to local patients.

Hospital authorities emphasized that this achievement reflects their ongoing mission to deliver world-class eye care in Uttar Pradesh. By introducing MIGS technologies like iStent Inject W, the institution aims to reduce the burden of glaucoma-related blindness and improve long-term outcomes for patients.

About Indira Gandhi Eye Hospital

Indira Gandhi Eye Hospital is a leading center for comprehensive ophthalmic care, offering advanced diagnostic and surgical services across subspecialties including glaucoma, cataract, retina, and cornea. The hospital continues to set benchmarks in patient care, innovation, and surgical excellence.

The Lucknow centre is led by Medical Director Dr Anjum Mazhari.

First i-Stent MIGS Surgery Performed in Jamshedpur by Dr. Nitesh Singh at ASG Eye Hospitals

First i-Stent MIGS Surgery Performed in Jamshedpur by Dr. Nitesh Singh at ASG Eye Hospitals

Jamshedpur, Jharkhand – March 27, 2026 – ASG Eye Hospitals, a leading chain of super-specialty eye care facilities, proudly announces a groundbreaking achievement in glaucoma treatment. Dr. Nitesh Singh, COO and Regional Director of ASG Eye Hospitals Jamshedpur, successfully performed the first-ever i-Stent Micro-Invasive Glaucoma Surgery (MIGS) in the city of Jamshedpur.

This advanced procedure marks a significant step forward in providing cutting-edge, minimally invasive care for patients suffering from glaucoma, a leading cause of irreversible blindness worldwide.

The i-Stent (or iStent inject®) is a revolutionary trabecular micro-bypass device—the smallest medical implant used in the human body. Made of biocompatible titanium and heparin-coated for safety, it is implanted through a tiny incision (often during cataract surgery) to create a permanent pathway that enhances the eye’s natural fluid drainage. By bypassing blockages in the trabecular meshwork and restoring outflow to Schlemm’s canal, the procedure effectively lowers intraocular pressure (IOP) with a highly favorable safety profile.

Unlike traditional glaucoma surgeries, which can involve more extensive interventions and higher risks, MIGS with i-Stent offers:

  • Minimal tissue disruption
  • Rapid recovery
  • Reduced dependence on glaucoma eye drops
  • Excellent long-term outcomes supported by extensive clinical evidence and peer-reviewed studies

This achievement reflects our commitment to bringing world-class, innovative treatments to the people of Jamshedpur and surrounding regions,” said Dr. Nitesh Singh. “Glaucoma often progresses silently, but with procedures like i-Stent MIGS, we can now offer safer, more effective options to preserve vision and improve quality of life for our patients. We are proud to be the first in the city to introduce this gold-standard technology.”

ASG Eye Hospitals continues to prioritize patient-centric care, adopting the latest global advancements in eye health. This milestone underscores the hospital’s dedication to excellence and accessibility in specialized treatments.

For more information about i-Stent MIGS, glaucoma management, or to schedule a consultation, please contact:

ASG Eye Hospitals, Jamshedpur

Ambagan, Sakchi, Jamshedpur, Jharkhand

Phone: 1800 1211 804 | 0657-244505 | 0657-244404

Latest Technology of glaucoma treatment at MediVision

Latest Technology of glaucoma treatment at MediVision

MediVision eye care centre, a trusted NABH accredited super-specialty eye hospital in Hyderabad, is thrilled to announce introduction of the revolutionary iStent Inject and iStent Inject W technology for treatment of glaucoma and cataract patients.

Glaucoma nicknamed the “Silent Thief of Sight” is one of the world’s most common cause of irreversible blindness. Traditional treatment includes use of long-term medication in the form of eyedrops or invasive surgery, both of which have potential side effects and complications. MIGS (Minimally Invasive Glaucoma Surgery) as the name suggest offers a less invasive, safer alternative for treatment of glaucoma, making it more manageable and less cumbersome for patients. iStent Inject is the most cutting edge MIGS, especially benefitting patients with mild to moderate glaucoma, offering freedom from multiple medication.

Benefits of iStent technology for glaucoma patients:

  1. High safety profile, less invasive option with minimal alteration of normal anatomy
  2. Minimal post operative discomfort, quick recover, fewer complications
  3. Advantage of being combined with cataract procedure in a single sitting

Expert Endorsements:

Dr. Rupak Kumar Reddy, senior Cataract surgeon has recently implanted the iStent Inject. He highlights the ease of its use, advantage of no additional incisions and high safety profile.

Dr. Meena Thotakura, Glaucoma consultant and surgeon, also shared her experience with the iStent Inject, stating that it will be a boon for patients, especially those in earlier stages, where they would have had to use lifelong anti glaucoma medications.

About MediVision eye care Centre:

MediVision Eye Care Centre is a trusted NABH Accredited Super-Specialty Eye Hospital established in 1993 by renowned ophthalmologist Dr. K. Ravi Kumar Reddy. With over 31 years of dedicated service. They have performed more than 135,000 successful eye procedures, driven by their commitment to provide top-quality and affordable eye care services to all.

Our expert team of 20 doctors and 200 support staff provide comprehensive patient care with emphasis on compassion, integrity and excellence. Their 50-bedded Super-specialty Eye Hospital equipped with state-of-the-art infrastructure including Robotic Cataract surgery unit, World class refractive centre including the latest SILK- ELITA, offers various solutions for cataract, glaucoma, corneal and Vitreo retinal problems, all under a single roof.